Esketamine

ATC N06AX27 · 10 markets · 24 records

Esketamine 10 markets · 24 records Forms

GB 11 records · 4 strengths

50 mg/2 mLinjectionKetanest S 25mg/5ml solution for injection ampoules+2Vesierra 50mg/2ml solution for injection ampoules、__no_trade__
25 mg/5 mLinjectionKetanest S 25mg/5ml solution for injection ampoules+2Vesierra 50mg/2ml solution for injection ampoules、__no_trade__
250 mg/10 mLinjectionNo trade name
28 mg/0.2 mLtopicalSpravato 28mg/0.2ml nasal spray unit dose

AU 5 records · 3 strengths

32.3 mginhalationSPRAVATO esketamine (as hydrochloride) 28 mg per 2 actuations nasal spray solution unknown
28 mg/2 actuationstopicalSpravato

Records without a stated strength · 1 Spravato

US 1 records · 1 strengths

28 mg/0.2 mLliquidSpravato

CA 1 records · 1 strengths

14 mgliquidSpravato

SG 1 records · 1 strengths

28 mg/vialtopicalSPRAVATO NASAL SPRAY 28MG/VIAL

ES 1 records · 1 strengths

28 mgnasalSpravato

MX 1 records · 1 strengths

Records without a stated strength · 1 Spravato

TW 1 records · 1 strengths

Records without a stated strength · 1 SPRAVATO (esketamine) Nasal Spray、速開朗鼻噴劑

HK 1 records · 1 strengths

Records without a stated strength · 1 SPRAVATO NASAL SPRAY 28MG/DEVICE

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Spravato

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.